Marker Therapeutics Inc - MRKR - stock price prediction, stock price target, analyst ratings from 3 analysts

Marker Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of 19.4%, and profit growth estimate of 2.6% for FY26, based on top 3 analyst calls.